Arkolith/Insider Trading/INBP/Form 4

Kay Christina

Co-Chief Executive Officer, Director, 10% OwnerINTEGRATED BIOPHARMA INC (INBP) · full profile →Form 4 · filed May 22, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 21, 2025Grant(A)144K$0.09$13K1.5M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 21, 2025Disposed to issuer(D)144K—$00

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001345281-25-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML